220 related articles for article (PubMed ID: 17121887)
41. Focal adhesion kinase is overexpressed in hepatocellular carcinoma and can be served as an independent prognostic factor.
Fujii T; Koshikawa K; Nomoto S; Okochi O; Kaneko T; Inoue S; Yatabe Y; Takeda S; Nakao A
J Hepatol; 2004 Jul; 41(1):104-11. PubMed ID: 15246215
[TBL] [Abstract][Full Text] [Related]
42. [Functions of spleen tyrosine kinase (Syk) gene and its correlation to neoplasms].
Wang HY; Zhang ZX
Ai Zheng; 2007 May; 26(5):555-60. PubMed ID: 17672952
[TBL] [Abstract][Full Text] [Related]
43. Research on the reactivation of Syk expression caused by the inhibition of DNA promoter methylation in the lung cancer.
Dong SW; Ma L; Xu N; Yan HQ; Liu HY; Li YW; Zhang P
Neoplasma; 2011; 58(1):89-95. PubMed ID: 21067271
[TBL] [Abstract][Full Text] [Related]
44. Reduced N-cadherin expression is associated with metastatic potential and poor surgical outcomes of hepatocellular carcinoma.
Zhan DQ; Wei S; Liu C; Liang BY; Ji GB; Chen XP; Xiong M; Huang ZY
J Gastroenterol Hepatol; 2012 Jan; 27(1):173-80. PubMed ID: 21777276
[TBL] [Abstract][Full Text] [Related]
45. Hypermethylation of NF-κB-Activating Protein-Like (NKAPL) Promoter in Hepatocellular Carcinoma Suppresses Its Expression and Predicts a Poor Prognosis.
Ng PKS; Lau CPY; Lam EKY; Li SSK; Lui VWY; Yeo W; Ng YK; Lai PBS; Tsui SKW
Dig Dis Sci; 2018 Mar; 63(3):676-686. PubMed ID: 29353445
[TBL] [Abstract][Full Text] [Related]
46. DNA methylation profiling identifies EYA4 gene as a prognostic molecular marker in hepatocellular carcinoma.
Hou X; Peng JX; Hao XY; Cai JP; Liang LJ; Zhai JM; Zhang KS; Lai JM; Yin XY
Ann Surg Oncol; 2014 Nov; 21(12):3891-9. PubMed ID: 24306662
[TBL] [Abstract][Full Text] [Related]
47. Cadherin/catenin complex appears to be intact in hepatocellular carcinomas from Australia and South Africa.
Herath NI; Walsh MD; Kew MC; Young J; Leggett BA; Macdonald GA
J Gastroenterol Hepatol; 2004 Jun; 19(6):676-82. PubMed ID: 15151624
[TBL] [Abstract][Full Text] [Related]
48. Clinicopathologic and prognostic values of apolipoprotein D alterations in hepatocellular carcinoma.
Utsunomiya T; Ogawa K; Yoshinaga K; Ohta M; Yamashita K; Mimori K; Inoue H; Ezaki T; Yoshikawa Y; Mori M
Int J Cancer; 2005 Aug; 116(1):105-9. PubMed ID: 15756681
[TBL] [Abstract][Full Text] [Related]
49. Correlation between promoter methylation in the GSTP1 gene and hepatocellular carcinoma development: a meta-analysis.
Li QF; Li QY; Gao AR; Shi QF
Genet Mol Res; 2015 Jun; 14(2):6762-72. PubMed ID: 26125884
[TBL] [Abstract][Full Text] [Related]
50. CHK1 targets spleen tyrosine kinase (L) for proteolysis in hepatocellular carcinoma.
Hong J; Hu K; Yuan Y; Sang Y; Bu Q; Chen G; Yang L; Li B; Huang P; Chen D; Liang Y; Zhang R; Pan J; Zeng YX; Kang T
J Clin Invest; 2012 Jun; 122(6):2165-75. PubMed ID: 22585575
[TBL] [Abstract][Full Text] [Related]
51. [Correlation between epigenetic alterations in the insulin growth factor-II gene and hepatocellular carcinoma].
Dong ZZ; Yao DF; Wu W; Qiu LW; Yao NH; Yan XD; Yu DD; Chen J
Zhonghua Gan Zang Bing Za Zhi; 2012 Aug; 20(8):593-7. PubMed ID: 23207153
[TBL] [Abstract][Full Text] [Related]
52. Activation of STAT3 signal pathway correlates with twist and E-cadherin expression in hepatocellular carcinoma and their clinical significance.
Zhang CH; Xu GL; Jia WD; Li JS; Ma JL; Ren WH; Ge YS; Yu JH; Liu WB; Wang W
J Surg Res; 2012 May; 174(1):120-9. PubMed ID: 21316706
[TBL] [Abstract][Full Text] [Related]
53. ASPM is a novel marker for vascular invasion, early recurrence, and poor prognosis of hepatocellular carcinoma.
Lin SY; Pan HW; Liu SH; Jeng YM; Hu FC; Peng SY; Lai PL; Hsu HC
Clin Cancer Res; 2008 Aug; 14(15):4814-20. PubMed ID: 18676753
[TBL] [Abstract][Full Text] [Related]
54. Epigenetic silencing of SFRP1 and SFRP5 by hepatitis B virus X protein enhances hepatoma cell tumorigenicity through Wnt signaling pathway.
Xie Q; Chen L; Shan X; Shan X; Tang J; Zhou F; Chen Q; Quan H; Nie D; Zhang W; Huang AL; Tang N
Int J Cancer; 2014 Aug; 135(3):635-46. PubMed ID: 24374650
[TBL] [Abstract][Full Text] [Related]
55. Methylation of S100A8 is a promising diagnosis and prognostic marker in hepatocellular carcinoma.
Liu K; Zhang Y; Zhang C; Zhang Q; Li J; Xiao F; Li Y; Zhang R; Dou D; Liang J; Qin J; Lin Z; Zhao D; Jiang M; Liang Z; Su J; Gupta VP; He M; Yang X
Oncotarget; 2016 Aug; 7(35):56798-56810. PubMed ID: 27462864
[TBL] [Abstract][Full Text] [Related]
56. Integrative analysis of aberrant Wnt signaling in hepatitis B virus-related hepatocellular carcinoma.
Ding SL; Yang ZW; Wang J; Zhang XL; Chen XM; Lu FM
World J Gastroenterol; 2015 May; 21(20):6317-28. PubMed ID: 26034368
[TBL] [Abstract][Full Text] [Related]
57. Hypermethylation of the spleen tyrosine kinase promoter in T-lineage acute lymphoblastic leukemia.
Goodman PA; Burkhardt N; Juran B; Tibbles HE; Uckun FM
Oncogene; 2003 Apr; 22(16):2504-14. PubMed ID: 12717427
[TBL] [Abstract][Full Text] [Related]
58. Spleen tyrosine kinase functions as a tumor suppressor in melanoma cells by inducing senescence-like growth arrest.
Bailet O; Fenouille N; Abbe P; Robert G; Rocchi S; Gonthier N; Denoyelle C; Ticchioni M; Ortonne JP; Ballotti R; Deckert M; Tartare-Deckert S
Cancer Res; 2009 Apr; 69(7):2748-56. PubMed ID: 19293188
[TBL] [Abstract][Full Text] [Related]
59. microRNA-146a inhibits cancer metastasis by downregulating VEGF through dual pathways in hepatocellular carcinoma.
Zhang Z; Zhang Y; Sun XX; Ma X; Chen ZN
Mol Cancer; 2015 Jan; 14():5. PubMed ID: 25608619
[TBL] [Abstract][Full Text] [Related]
60. [Aberrant methylation of multiple genes and its clinical implication in hepatocellular carcinoma].
Lou C; Yang B; Gao YT; Wang YJ; Nie FH; Yuan Q; Zhang CL; Du Z
Zhonghua Zhong Liu Za Zhi; 2008 Nov; 30(11):831-6. PubMed ID: 19173828
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
